A study reveals that Atogepant, a new migraine prevention drug, offers immediate relief from migraines from the first day of ...

For people with multiple sclerosis (MS), having a COVID-19 infection is not associated with worsening MS symptoms or ...

Amber Salter, PhD, study author of UT Southwestern Medical Center in Dallas, Texas, and a member of the American Academy of Neurology The study involved 2,132 adults with MS ... They were asked about ...

Those who experience back pain will generally benefit from sleeping on a medium-firm pillow. These pillows don't have too ...

First Bite Syndrome is a rare, but treatable, condition that typically occurs in people who have had face or neck surgery.

The FDA's Center for Veterinary Medicine posted a letter alerting veterinarians of adverse health effects in dogs from ...

and neurological function at 1 year, even when the cancer had metastasized to brain, an analysis of data from the DESTINY-Breast12 trial shows. For 504 patients with or without brain metastases at ...

Groundbreaking clinical trial reveals the first long-term neurological improvements in chronic spinal cord injury patients ...

Sangamo Therapeutics, Inc. has groundbreaking treatments for neuropathic pain and Hemophilia A. Click for my updated look at ...

Mixed results from a study focused on lower back pain left analysts wanting as well as confused about Vertex's plans to forge ...

The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced that it has ...